Prot: 254PD101- A Phase 1 Single- and Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB094 Administered Intrathecally to Adults With Parkinson’s Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date11/27/19 → 11/30/24

Funding

  • Quintiles, Inc. (Prot: 254PD101 // Prot: 254PD101)
  • Biogen MA Inc. (Prot: 254PD101 // Prot: 254PD101)